[Coronary artery bypass surgery in patients with symptomatic or asymptomatic internal carotid artery stenosis]

Julia Jedrzejewska1, Anna Członkowska, Adam Kobayashi

  • 1II Klinika Neurologii, Instytut Psychiatrii i Neurologii w Warszawie, 02-957 Warszawa. jedrzej@ipin.edu.pl

Insights

Arteriosclerosis affects multiple systems, often linking carotid artery disease with coronary artery disease. Management guidelines are lacking for patients needing coronary artery bypass graft surgery with concurrent carotid stenosis, posing risks of stroke and heart attack.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Neurology

Context:

  • Arteriosclerosis is a multisystem disease with known links between carotid and coronary artery disease.
  • Significant carotid stenosis incidence in patients undergoing coronary artery bypass graft (CABG) surgery ranges from 3% to 22%.
  • Hemodynamically significant carotid disease affects 2.8% to 7.8% of patients.

Purpose:

  • To highlight the challenges in managing patients with concurrent carotid and coronary artery stenosis.
  • To underscore the lack of clear guidelines for managing these complex cases.
  • To emphasize the risks of periprocedural stroke and myocardial infarction associated with carotid interventions in CABG patients.

Summary:

  • Management of patients with concomitant coronary and carotid stenosis is complex due to varying degrees of stenosis and patient symptoms.
  • Carotid interventions, necessary for stenosis, carry inherent risks of stroke and myocardial infarction.
  • There is a critical need for definitive guidelines to mitigate periprocedural cardiac and cerebrovascular events in patients undergoing CABG with carotid stenosis.

Impact:

  • Informs clinical decision-making for a challenging patient population.
  • Highlights a gap in current medical guidelines.
  • Emphasizes the importance of multidisciplinary approaches to patient care and risk reduction.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...